Efficacy and safety of apatinib in patients with recurrent or refractory melanoma.

被引：0
|
作者：
Wang, Zibing
Yuan, Shumin
Zhang, Xiaojie
Huang, Hao
Gao, Quanli
机构：
[1] Zhengzhou Univ, Dept Immunotherapy, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[2] Henan Canc Hosp, Zhengzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22026
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma
    Yuan, Shumin
    Fu, Qiang
    Zhao, Lingdi
    Fu, Xiaomin
    Li, Tiepeng
    Han, Lu
    Qin, Peng
    Ren, Yingkun
    Huo, Mingke
    Li, Zhimeng
    Lu, Chaomin
    Yuan, Long
    Gao, Quanli
    Wang, Zibing
    ONCOLOGIST, 2022, 27 (06): : E463 - E470
  • [2] Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma (vol 28, oyab068, 2022)
    Yuan, S.
    Fu, Q.
    Zhao, L.
    ONCOLOGIST, 2022, 27 (08): : E684 - E684
  • [3] Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma
    Hao Lin
    Xinli Zhou
    Xiaofang Sheng
    Xiaohua Liang
    Drugs in R&D, 2023, 23 : 239 - 244
  • [4] Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma
    Lin, Hao
    Zhou, Xinli
    Sheng, Xiaofang
    Liang, Xiaohua
    DRUGS IN R&D, 2023, 23 (03) : 239 - 244
  • [5] A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients
    Yang, Mi
    Liu, Xiufeng
    Zhang, Cheng
    Liao, Feng
    Li, Zixiong
    Luo, Xianwen
    Sun, Yiran
    Chen, Chao
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8869 - 8876
  • [6] Retrospective analysis of safety and efficacy of ipilimumab in elderly patients with advanced melanoma.
    Shaw, Andrew Cota
    VanAnh Trinh
    Bassett, Roland L.
    Glitza, Isabella Claudia
    Diab, Adi
    Amaria, Rodabe Navroze
    Tawbi, Hussein Abdul-Hassan
    Davies, Michael A.
    Hwu, Wen-Jen
    Hwu, Patrick
    Patel, Sapna Pradyuman
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Efficacy and safety of apatinib in patients with metastatic colorectal cancer refractory to standard therapies
    Lv, Wangxia
    Yuan, Meiqin
    Zhao, Yazheng
    Shi, Zhong
    Yang, Yunshan
    Zhong, Haijun
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (02) : 420 - 427
  • [8] The efficacy and safety of apatinib in patients with metastatic colorectal cancer refractory to standard therapies.
    Lv, Wangxia
    Yuan, Meiqin
    Yang, Yunshan
    Shi, Zhong
    Zhong, Haijun
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Phase 2, multicenter, safety and efficacy study of pidilizumab in patients with metastatic melanoma.
    Atkins, Michael B.
    Reiney, Ragini
    Sznol, Kudchadkar Mario
    McDermott, David F.
    Lotem, Michal
    Schachter, Jacob
    Wolchok, Jedd D.
    Urba, Walter John
    Kuzel, Timothy
    Schuchter, Lynn Mara
    Slingluff, Craig L.
    Ernstoff, Marc S.
    Fay, Joseph W.
    Friedlander, Philip Adam
    Gajewski, Thomas
    Zarour, Hassane M.
    Rotem-Yehudar, Rinat
    Sosman, Jeffrey Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study
    Yu, Jiangtao
    Xu, Ziwen
    Li, Anyang
    Zhang, Jindi
    Wang, Yi
    Zhao, Hongqin
    Zhu, Haiyan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 3419 - 3424
12345